Florida Society Of Clinical Oncology, Inc.

What Florida Society Of Clinical Oncology, Inc. does

FLASCO (Florida Society of Clinical Oncology, Inc.) is a member-supported 501(c)(3) nonprofit professional society founded in 1977 and headquartered in Tampa, Florida. The organization serves as "The Voice of Oncology in Florida," aggregating a network of more than 8,100 oncology healthcare clinicians including medical oncologists, radiation oncologists, surgical oncologists, gynecologic oncologists, hematologists, pathologists, pharmacists, advanced practice providers, oncology nurses, fellows, residents, and practice administrators across Florida, Puerto Rico, and the U.S. Virgin Islands. Its mission is to facilitate multidisciplinary efforts that improve oncology patient care through education, advocacy, networking, and clinical practice support.

The core offering is a portfolio of educational programs and member services rather than a technology product. Programs include the Spring Congress (with the Business of Oncology Summit), the Fall Oncology Congress (five specialized tracks: Multidisciplinary, Pharmacy, APP, Nurse/Navigator, Administrator), the FLASCO Clinical Oncology Series covering disease-specific topics (Breast, GI, Lung, Multiple Myeloma, Classical Hematology, Neuro-Oncology, Rare Disease, Malignant Heme), the FLASCO Breaking Barriers Summit, the Cancer Disparities & Health Equity Summit, the Puerto Rico Oncology Symposium, the Fellows & Residents Training Program, the OCN Prep Course, the Rapid Integrations Training Program, and Great Strides Together. Supporting digital assets include the FLASCO Frontline weekly newsletter, the monthly Clinical Practice and Administrators newsletter, the OncoPod podcast, the FLASCO Patient Portal, the OncoFeatures content series, and on-demand webinars distributed via YouTube and ReachMD.

The business model is a nonprofit, sponsorship-and-donation-driven model. Membership is complimentary for doctoral-level professionals, non-doctoral healthcare professionals, students, and physicians-in-training through December 31, 2027, with a loyalty mechanic that extends free membership for two additional years after attending two sponsored events. Revenue is generated primarily through tiered Corporate Partnerships with pharmaceutical and biotech companies (Presidential, Elite, Diamond, Platinum, Gold tiers), private donations, and selected event registration fees. Named Corporate Partners include AbbVie, Amgen, Bristol Myers Squibb, Merck, Pfizer Oncology (Presidential tier); AstraZeneca, Gilead Sciences, Genentech (Elite); and Novartis (Platinum). Distribution is primarily through the flasco.org membership portal, in-person congresses across Florida, on-demand webinars, and digital newsletters. FLASCO is governed by a Board of Directors (up to 45 members) and is led by Executive Director Julie Newberry, Senior Director of Operations and Business Development Amanda Bridges, and a physician Executive Committee currently headed by President Edgardo Santos, MD, FACP, FASCO.

Name

Florida Society Of Clinical Oncology, Inc.

Legal name

Florida Society of Clinical Oncology

Website

https://flasco.org

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

1–10 employees

Short description

FLASCO is a 501(c)(3) nonprofit professional society founded in 1977 that serves more than 8,100 oncology healthcare clinicians in Florida, Puerto Rico, and the U.S. Virgin Islands through education, advocacy, networking, and clinical practice support, funded primarily by tiered pharmaceutical corporate partnerships.

Ownership category

akta.pro rank

Product category

Professional Association Services

NAICS

Political Organizations (81394)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

akta.pro secondary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Oncology professional society
• Medical education programs
• Healthcare advocacy services
• Clinical oncology events
• Professional membership organization

Headquarters

HQ city

Riverview

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Corporate Memberships: Pharmaceutical and biotech companies sponsor FLASCO at various tiers (Presidential, Elite, Diamond, Platinum, Gold) providing financial support in exchange for visibility, educational engagement, and networking opportunities with Florida oncology professionals.
2. Private Donations: Individual donations support the organization's mission and initiatives.
3. Event Registration Fees: Some events and educational programs may have registration fees, particularly for non-members or certain specialty programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

FLASCO is a member-supported statewide professional society that delivers oncology education, advocacy, networking, and practice support to healthcare professionals in Florida, Puerto Rico, and the U.S. Virgin Islands. Its core offerings include multi-track annual congresses, disease-specific clinical series, fellowship training programs, certification prep courses, patient education programs, corporate sponsorship tiers, and tiered professional membership. The organization also publishes a weekly e-newsletter, hosts a podcast and webinar library, and coordinates legislative advocacy with national oncology societies.

Product overview

FLASCO (Florida Society of Clinical Oncology) is a member-supported statewide professional society serving as 'The Voice of Oncology in Florida' with over 8,100+ oncology healthcare clinicians. Rather than a technology product company, FLASCO provides a portfolio of educational programs, professional development services, and member resources including: the FLASCO Living With Series (patient education programs), FLASCO Frontline weekly eNewsletter, FLASCO OncoPod podcast, and the FLASCO Patient Portal. The organization hosts major annual events including the Spring Congress (featuring the Business of Oncology Summit), Fall Oncology Congress, Breaking Barriers Summit, Cancer Disparities & Health Equity Summit, Puerto Rico Oncology Symposium, and the FLASCO Clinical Oncology Series covering disease-specific topics. Supporting programs include the Fellows & Residents Training Program, OCN Prep Course, Rapid Integrations Training Program, Great Strides Together, and the Professional Partnership and Corporate Partnership Programs. The FLASCO Oncology Captains Program provides disease-specific thought leadership.

Differentiator

Problem solved

Functional benefit

Products and services

• FLASCO Membership Program

Quantifiable outcome

• Complimentary membership extended through December 31, 2027
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

17 partnerships are on record, tiered key partner, presidential partner, elite partner, platinum partner, core partner, national partner, advocacy partner and state partner.

• Florida Cancer Specialists & Research Institutekey partnerStrategic or Co-development Partner · 24 October 2025Major Florida oncology practice whose clinicians actively participate in FLASCO events. FCS experts led sessions at the FLASCO Fall Oncology Congress covering onco-fertility, molecular genomics, and pharmacy operations.
• AbbViepresidential partnerGTM or Marketing PartnerPresidential Partner of FLASCO. AbbVie is a pharmaceutical company focused on immunology, oncology, neuroscience, and other therapeutic areas. As a Presidential Partner, AbbVie supports FLASCO's educational initiatives and gains access to Florida oncology professionals.
• Amgenpresidential partnerGTM or Marketing PartnerPresidential Partner of FLASCO. Amgen is a biotechnology company focused on human therapeutics. Supports FLASCO programs and engages with the Florida oncology community through partnership.
• Bristol Myers Squibbpresidential partnerGTM or Marketing PartnerPresidential Partner of FLASCO. Bristol Myers Squibb is a global pharmaceutical company with significant oncology portfolio. Supports FLASCO educational initiatives.
• Merckpresidential partnerGTM or Marketing PartnerPresidential Partner of FLASCO. Merck is a global pharmaceutical company with Keytruda and other oncology products. Supports FLASCO programs and member education.
• Pfizer Oncologypresidential partnerGTM or Marketing PartnerPresidential Partner of FLASCO. Pfizer Oncology division focuses on innovative cancer treatments. Supports FLASCO educational programming.
• AstraZenecaelite partnerGTM or Marketing PartnerElite Partner of FLASCO. AstraZeneca is a global biopharmaceutical company with growing oncology portfolio including Imfinzi andEnhertu. Partners with FLASCO for education and access.
• Gilead Scienceselite partnerGTM or Marketing PartnerElite Partner of FLASCO. Gilead Sciences includes oncology through subsidiary Kite Pharma (Yescarta). Partners with FLASCO for member engagement.
• Genentechelite partnerGTM or Marketing PartnerElite Partner of FLASCO. Genentech, part of Roche Group, is a biotechnology pioneer with significant oncology products. Supports FLASCO education.
• Novartisplatinum partnerGTM or Marketing PartnerPlatinum Partner of FLASCO. Novartis is a global pharmaceutical company with broad oncology portfolio. Partners with FLASCO for member education.
• Association of Community Cancer Centers (ACCC)core partnerStrategic or Co-development PartnerFLASCO provides automatic ACCC membership to all members. ACCC is a collaborative organization helping cancer programs and practices adapt to the complex cancer care environment.
• ASCO (American Society of Clinical Oncology)national partnerStrategic or Co-development PartnerFLASCO partners with ASCO at the national level including Capitol Hill Day events. ASCO's Young Investigator Award ($60,000) is funded through FLASCO for Florida Fellows.
• ASH (American Society of Hematology)national partnerStrategic or Co-development PartnerFLASCO collaborates with ASH on legislative and advocacy efforts. ASH Liaison serves on FLASCO Executive Committee.
• American Cancer Societyadvocacy partnerStrategic or Co-development PartnerFLASCO brings unified Florida voice in collaboration with American Cancer Society on behalf of Florida cancer patients.
• Leukemia & Lymphoma Societyadvocacy partnerStrategic or Co-development PartnerFLASCO collaborates with Leukemia/Lymphoma Society on legislative advocacy efforts for Florida cancer patients.
• Florida Medical Associationstate partnerStrategic or Co-development PartnerFLASCO works with Florida Medical Association on legislative efforts and state-level advocacy.
• COA (Community Oncology Alliance)national partnerStrategic or Co-development PartnerFLASCO partners with COA at national level including Capitol Hill Day advocacy efforts.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Oncology Nursing Society (ONS): The professional society for oncology nurses, with comparable scope to FLASCO's nursing-track programs (e.g., OCN prep, Great Strides Together). A close parallel in mission and educational portfolio, but focused on the nursing specialty specifically.
• American Society of Clinical Oncology (ASCO): The national professional society for oncologists and the de facto parent body of state oncology societies like FLASCO. Comparable as an oncology-focused member organization delivering CME, advocacy, and clinical guidelines, though at national scale and with a paid-dues model.
• American Association for Cancer Research (AACR): A major cancer research-focused professional society with a similar member-supported model, corporate sponsorship structure, and educational meetings portfolio to FLASCO, operating at the national and international levels.
• American Society of Hematology (ASH): The national professional society for hematologists, with deep overlap in clinical oncology and joint advocacy with FLASCO. A sister society to FLASCO at the national level, sharing similar member-services, education, and policy engagement models.
• National Comprehensive Cancer Network (NCCN): An alliance of leading academic cancer centers producing oncology guidelines, education, and policy. Comparable as a nonprofit oncology organization funded in part by industry supporters and delivering continuing education to clinical oncology professionals.

Direct peers

• Association of Community Cancer Centers (ACCC): A multidisciplinary organization serving oncology program administrators, nurses, pharmacists, and practice leaders across community cancer programs. Highly comparable to FLASCO in member scope, corporate partnership model, and educational mission; FLASCO even provides automatic ACCC membership to all of its members.
• Community Oncology Alliance (COA): A nonprofit advocacy organization dedicated to preserving community-based oncology care. Directly comparable to FLASCO's advocacy function and federal-level lobbying orientation; FLASCO and COA already collaborate on Capitol Hill Day events.
• Carolinas Society of Clinical Oncology: A regional state-level clinical oncology society serving North and South Carolina. Closely parallel to FLASCO in scope (multidisciplinary oncology members, CME programming, corporate partnership tiers, and advocacy), differing primarily by geography.
• Michigan Society of Hematology and Oncology: A state-level professional society for hematologists and oncologists in Michigan with a comparable mix of CME programming, advocacy, and corporate partnerships. Represents the same state-level oncology society model as FLASCO, but in a different geography.

Regional players

• Florida Medical Association: The statewide professional society for all Florida physicians. FLASCO works with the FMA on state-level legislative advocacy. Comparable as a Florida-based physician member organization, but broader in clinical scope and an order of magnitude larger.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@floridasocietyofclinicalon9952
• LinkedInlinkedin.com/company/florida-society-of-clinical-oncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Florida Society Of Clinical Oncology, Inc.